Active warning — SupplementIndex Safety Review: FDA import alert. Aristolochic acid — IARC Group 1 carcinogen.
Updated: 2026-05-29 · v2.0 · Prof. G. Pkhakadze, MD, MPH, PhDCiteEditorial
📰Read the full Aristolochia evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.
5
Avoid
Aristolochia
Aristolochia spp. (aristolochic acid)
BannedStrongRestricted
RDA
PROHIBITED — carcinogen
Target
N/A
Upper limit
NO safe dose
Products
Dosage by population group — reference
⚠ DANGEROUS — see overview [1]
ℹ️ Not obtained from food. Not applicable — this substance is not a dietary nutrient and should not be consumed as food.
🔬 Lab interpreter
ℹ️ No validated blood test. There is no established laboratory test to assess status or guide dosing for this ingredient. Clinical response and symptoms are the practical guide.
⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Aristolochic acid is one of the MOST POTENT HUMAN CARCINOGENS known — causes kidney failure + bladder cancer with a specific mutational signature. Belgian nephropathy: >100 renal failures. Balkan nephropathy: endemic from contaminated grain. BANNED globally but still found in TCM products under various names. ANY TCM product containing 'Mu Tong,' 'Fang Ji,' 'Xi Xin,' or other Aristolochia-associated names must be verified [1].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
ABSOLUTELY CONTRAINDICATED — carcinogen + nephrotoxin [1].
👦 Pediatric: See guidance
ABSOLUTELY NOT [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose

How to take

🍽 Timing: DO NOT USE [1].
💊 With food: N/A [1].
🚫 Avoid: COMPLETELY [1].
2 Which form?
FormBioavailabilityVeganCost
['See overview', 'restricted/banned', 'See overview [1].']StandardCheck label
3 Common questions
DANGER
Aristolochic acid is one of the MOST POTENT HUMAN CARCINOGENS known — causes kidney failure + bladder cancer with a specific mutational signature. Belgian nephropathy: >100 renal failures. Balkan nephropathy: endemic from contaminated grain. BANNED globally but still found in TCM products under various names. ANY TCM product containing 'Mu Tong,' 'Fang Ji,' 'Xi Xin,' or other Aristolochia-associated names must be verified [1].
4 Clinical evidence

Strong

See overview [1]. HIGH

Moderate

See overview [1]. MODERATE

Insufficient

See overview [1]. LOW
5 Safety, toxicity & adverse events

Absolute contraindications

✕ Banned — aristolochic acid is a potent nephrotoxin and human carcinogen causing irreversible kidney failure and urothelial cancer
✕ Any use at any dose
✕ Any kidney condition

Relative

⚠ No safe dose exists

🚩 Red flags

DANGEROUS — see overview [1]
6 Interactions

Drug interactions

See overview Lethal/major
Action: DO NOT USE [1].
7 Cite this page
Vancouver: Pkhakadze G. Aristolochia — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/ingredients/aristolochia/
APA 7th: Pkhakadze, G. (2026). Aristolochia — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/aristolochia/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: January 2027
References: 1 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Aristolochia — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/aristolochia/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG